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Autoprocessing of neutrophil elastase near its
active site reduces the efficiency of natural and
synthetic elastase inhibitors
T. Dau1, R.S.J. Sarker1, A.O. Yildirim1, O. Eickelberg1 & D.E. Jenne1,2
An imbalance between neutrophil-derived proteases and extracellular inhibitors is widely
regarded as an important pathogenic mechanism for lung injury. Despite intense efforts over
the last three decades, attempts to develop small-molecule inhibitors for neutrophil elastase
have failed in the clinic. Here we discover an intrinsic self-cleaving property of mouse
neutrophil elastase that interferes with the action of elastase inhibitors. We show that
conversion of the single-chain (sc) into a two-chain (tc) neutrophil elastase by self-cleavage
near its S1 pocket altered substrate activity and impaired both inhibition by endogenous
a-1-antitrypsin and synthetic small molecules. Our data indicate that autoconversion
of neutrophil elastase decreases the inhibitory efficacy of natural a-1-antitrypsin and small-
molecule inhibitors, while retaining its pathological potential in an experimental mouse
model. The so-far overlooked occurrence and properties of a naturally occurring tc-form
of neutrophil elastase necessitates the redesign of small-molecule inhibitors that target the
sc-form as well as the tc-form of neutrophil elastase.
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N
eutrophil elastase is abundantly expressed by neutrophil
precursors in bone marrow and stored in primary
(azurophil) granules in its mature active form. During
inflammation, NE is released into the extracellular space, where
its activity is tightly contained by alpha-1-antitrypsin (AAT), an
abundant neutrophil elastase inhibitor of blood plasma. Intra-
tracheal instillation of human neutrophil elastase and porcine
pancreas elastase into an animal model lead to emphysema and
was the first indication that an imbalance between neutrophil
elastase and AAT is an important pathogenic mechanism for lung
injury1,2. Both environmental factors like cigarette smoke or air
pollution and genetic factors can lead to a disruption of the
protease–antiprotease balance3–5. While other locally acting
elastase inhibitors, for example, secretory leukocyte protease
inhibitor and elafin6,7, also provide some anti-elastase protection
in humans, only decreased levels of plasma AAT are known to be
associated with chronic lung disease. Inherited deficiency
including the complete absence of AAT, in particular, is
associated with emphysema and chronic obstructive pulmonary
disease development indicating that intermittently unopposed
neutrophil elastase activity can damage lung tissues8. Although
augmentation therapy has been accepted as a treatment of AAT
deficiency, less cost-intensive alternatives, in particular small-
molecule inhibitors for neutrophil elastase, have failed in the
clinic despite many efforts over the last three decades.
During our characterization of mouse neutrophil elastase, we
discovered a spontaneous conversion process of the single-chain
(sc) form of neutrophil elastase into a specific two-chain (tc) form
by self-cleavage near its S1 pocket. The tc neutrophil elastase
showed altered substrate activity and inhibition by AAT as well as
by a small-molecule inhibitor. While autoprocessing of neutrophil
elastase decreased the inhibitory ability of AAT and synthetic
small-molecule inhibitors, the pathological potential of tc
neutrophil elastase was retained. The occurrence of the so-far
unnoticed tc neutrophil elastase with its altered properties
adversely affects the protease–antiprotease balance in the lung
during neutrophil elastase release in response to external
challenges and should be considered for the development of
more efficient anti-elastase therapies.
Results
Identification of two internal cleavage sites. At the high con-
centrations (estimates are up to 5 mM) immediately reached after
granule secretion9, neutrophil elastase is able to nick itself,
resulting in an altered activity of neutrophil elastase (Fig. 1a).
This self-nicking activity was routinely observed in vitro already
at much lower concentrations than 5 mM when the propeptide
was removed by enterokinase. Conversion into the mature form
was achieved as demonstrated by SDS–polyacrylamide gel
electrophoresis (SDS–PAGE). Besides the mature sc-form of
mouse neutrophil elastase, two bands (band 3 and 4) were
generated in increasing amounts over time. Using Edman
sequencing, we identified these bands as amino-terminal
fragments of mouse neutrophil elastase starting with the mature
N terminus, namely Ile16-Val17 (Fig. 1b, chymotrypsinogen
numbering according to Bode et al.10). The predominant
carboxyl-terminal fragment (outside the gel sections shown in
Fig. 1) started at position 189 with Gly189, the minor fragment
with Cys182 (Fig. 1b). Nicking of mouse neutrophil elastase also
continued after adding an enterokinase specific inhibitor
(DDDK-chloromethylketone) pointing to a self-cleavage of
mature mouse neutrophil elastase. These bands did not appear,
when we processed the catalytically inactive Ser195Ala variant of
mouse neutrophil elastase under the same conditions (Fig. 1c).
Cleavage after Ala188 preceded the cleavage at the minor nick site
after Val181. Both nick sites are located on the surface and are
consistent with the cleavage specificity of both human neutrophil
elastase and mouse neutrophil elastase. The carboxyl-terminal
fragments carrying the active site Ser195 cannot be released
from the native molecule as the native structure of neutrophil
elastase is stabilized by a conserved disulfide bond between
Cys136 and Cys201 (Fig. 1b).
Inactivation by a second internal cleavage. Using the same
extended peptide sequence Abz-GAVVASELR-Y(NO2)-D as a
substrate and normalizing all measurements to the highest
activity in each experiment (n¼ 3), we still detected high activity
for the tc-form of neutrophil elastase (Fig. 1a) although somewhat
less than with sc neutrophil elastase (Fig. 1d). Internal cleavage of
neutrophil elastase, therefore, did not inactivate this enzyme by
contrast to a degradation-sensitive variant (Gly186Arg, chymo-
trypsinogen number) of anionic trypsin, which inactivates itself
by cleavage at a slightly different topological position11. To
confirm the catalytic activity of the tc-form, we incubated it with
a biotinylated tetrapeptide chloromethylketone that forms an
irreversible covalent bond with the histidine residue of the
catalytic triad in active serine proteases12. As shown in Fig. 2,
both variants of the tc-form (corresponding to band 3 and band 4
of Fig. 1a) were labelled with this activity-dependent suicide
inhibitor. On closer inspection, the shorter amino-terminal
fragment, however, appeared to have reacted only partially in
comparison with the amounts of the two other forms present in
this preparation (Figs 2a and b, right lane). The non-reactive
fraction most likely represents elastase molecules with two
internal cleavages (Figs 2c, b and 4). This finding is consistent
with a moderate loss of elastase activity after prolonged
incubation times when both the sc-form and the tc-variant 1
had declined in quantity (Fig. 1a).
Conserved self-cleavages in neutrophil elastase and trypsin.
Self-cleavage of the same loop in another serine protease, bovine
cationic trypsin, has been described in the 1960s resulting
in a functionally active new trypsin species with altered chymo-
trypsin-like activity, called pseudotrypsin13. The critical
self-cleavage at Lys176/Asp177 (Lys188/Asp189, numbered
according to chymotrypsinogen)13 occurred at the same
topological position, as in mouse neutrophil elastase between
Ala188/Gly189 (Fig. 1e). Mass spectrometry-grade trypsins from
commercial sources are chemically methylated at Lys188 and
thereby retain their strict Arg/Lys specificity. Although the
surface loop 185 through 188 does not directly contact the
substrate, it plays a significant role in determining substrate
specificity14. To prove this particular position 188 as the critical
target for limited proteolysis in mouse neutrophil elastase, we
replaced the Gln187–Ala188 dipeptide with Lys187–Gly188 as
found in human azurocidin15, and successfully eliminated the
self-processing of natural mouse neutrophil elastase (Fig. 1b). By
repeating the experiment shown in Fig. 1a, we were able to verify
that this mutated mouse neutrophil elastase was stable and kept
its activity even after 24 h (Fig. 1d).
Tc neutrophil elastase found in human and murine neu-
trophils. Identical residues at position 188 and 189, namely Ala–
Gly, occur in many mammalian neutrophil elastase homologues
and are expected to trigger a natural autodigestive modification of
neutrophil elastase in general. Accordingly, the tc neutrophil
elastase was found in both murine and human polymorpho-
nuclear neutrophil (PMN) lysates (Fig. 3). Freshly isolated murine
and human PMNs were quickly lysed in reducing SDS sample
buffer and boiled to avoid any autodegradation of mouse
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neutrophil elastase during lysate preparation. The expected
mouse neutrophil elastase band at 27 kDa and the two bands
around 19 kDa are found in wild type, but not in PR3/NE double-
deficient PMN lysate16 confirming the specificity of the
antibodies. Haptoglobin served as a loading control17. In
contrast to mouse PMNs, human PMNs were lysed in the
presence of a biotinylated AAPV-chloromethylketone, an
irreversible activity-based inhibitor of both proteinase 3 and
neutrophil elastase. The covalently biotinylated neutrophil
elastase was then immunoprecipitated with a monoclonal
antibody specific for human neutrophil elastase and visualized
after SDS–PAGE and western blotting using streptavidin-
peroxidase. Our analyses conclusively demonstrate that self-
processing of neutrophil elastase occurs rapidly even with careful
preparation of unstimulated neutrophils from murine bone
marrow cells (Fig. 3a) and peripheral blood leukocytes
(Fig. 3b). Human neutrophil elastase preparations made from
sputum material also showed a similar pattern of fragmentation
when biotinylated AAPV-chloromethylketone was added
indicating that proteolytically modified neutrophil elastase is
present in biological fluids and retains its activity under these
conditions (Fig. 3b).
Altered substrate activity of the tc neutrophil elastase. To
search for a potential change of cleavage activity, preparations
of the tc mouse neutrophil elastase and sc mouse neutrophil
elastase were incubated with fluorescence resonance energy
transfer peptides derived from the reactive centre loop sequences
of AAT18,19 and serpinB1 (MNEI)20, the most relevant
mechanism-based inhibitors of neutrophil elastase in the
extracellular and cytosolic compartment, respectively (Table 1).
The primary effect of intramolecular self-cleavage was a
12.5-fold decrease in the catalytical constant (kcat), while the
Michaelis constant (Km) was marginally changed for the
hydrolysis of the AAT peptide sequence. A different
consequence has been found with the MNEI-derived peptide,
its Km was fivefold lower, indicating that the serpinB1-derived
peptide was binding fivefold more tightly, but its kcat value was
29-fold lower. The kcat values characterize the rate of product
formation encompassing an acylation and deacylation step which
both could be impaired. Studying the interaction between
neutrophil elastase and a pseudosubstrate, AAT, with the
formation of a covalent acyl complex, should give us a clue as






























































































Figure 1 | Self-cleavage of mouse neutrophil elastase after activation. (a) At time zero, enterokinase (25–50mg ml 1) was added to mouse neutrophil
elastase (1–2 mg ml 1) and processing of the mouse neutrophil elastase zymogen was analysed over 24 h by SDS–PAGE and Coomassie blue staining.
Activity at the same points in time were recorded using Abz-GAVVASELR-Y(NO2)-D as a fluorogenic substrate. Data shown are the mean±s.e.m. of all
experiments (n¼ 5) and was normalized to the time point (100%) showing the highest activity. Self-cleavage of mouse neutrophil elastase started
immediately and continued even in the presence of an enterokinase specific inhibitor (not shown). Activity declined in particular with the appearance of
band 3 and 4 of the tc neutrophil elastase. (b) Autoprocessed mouse neutrophil elastase (mNE; b, lane 1) was blotted onto Immobilon PVDF membrane
after SDS–PAGE (18% polyacrylamide Tris tricine gel) and the two low molecular weight bands (outside of the gel section depicted) were analysed by
Edman sequencing. The N terminus of these fragments started with sequences (grey arrow heads) shown in the alignment of wild-type murine neutrophil
elastase (wt mNE, middle row) and the mutated murine NE (mut mNE). Replacement of Gln187–Ala188 by Lys187–Gly188 as found in azurocidin prevents
the formation of band 3, the major tc-form (right lane, mut mNE). (c) Recombinant wt mNE and inactive mutant S195A mNE (0.47 mg ml 1) were
incubated with enterokinase EK (15mg ml 1) at 37 C for 24 h. Tc-mNE was only found with active wt mNE. (d) The experiment a was repeated with mut
mNE. Data shown are the mean±s.e.m. of all experiments (n¼ 5) and was normalized to the time point (100%) showing the highest activity. Mut mNE
shows some minor autoprocessing activity for the second internal site, but a highly stable activity for more than 24 h after enterokinase-mediated
conversion of its zymogen. (e) Bovine cationic trypsin (bTRYP, upper row) was aligned with mNE. The self-cleavage position of the so-called pseudotrypsin
with chymotrypsin-like activity is indicated by the grey arrow head pointing downward. C-ter, C-terminal; N-ter, N-terminal.
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Impaired inhibition of tc neutrophil elastase by AAT. We,
therefore, analysed the kinetics of complex formation between the
sc- and tc-form of mouse neutrophil elastase and AAT. As shown
in Table 2, the association rate constant of AAT with the tc-form
was 10-fold slower than that of sc neutrophil elastase. This dif-
ference in AAT reactivity was further confirmed by Coomassie
Brilliant Blue staining of the protein bands after SDS–PAGE
(Fig. 4). Complexes between the sc- and the tc-form can be easily
distinguished by their size difference, as a covalent complex is
formed between the active site serine of neutrophil elastase Ser195
and the methionine carboxyl group of the reactive centre loop of
AAT Met358. Reactivity with the tc-form is visualized by the
appearance of a band slightly larger than native AAT, while the
complex between the sc neutrophil elastase and AAT is easily
recognized as a 80-kDa band. The tc-related complex is formed
significantly slower than the 80-kDa complex in the presence of a
partially nicked wild-type neutrophil elastase.
Impaired inhibition of tc-elastase by a synthetic inhibitor.
Proteolytic modification at this position in neutrophil elastase
should similarly impair the inhibitory efficiency of small synthetic
chemicals. Because of their advantages for therapeutic applica-
tions, non-electrophilic reversible inhibitors have recently been
optimized for high-affinity binding to human neutrophil elastase.
One of these compounds, named AZ11777736, was kindly pro-
vided to us by AstraZeneca (Mölndal, Sweden). As expected, we
not only noticed a 10-fold decline in the association rate constant
between AAT and the tc mouse neutrophil elastase, but also a 14-
fold increase in the dissociation constant of this small-molecule
inhibitor and the tc mouse neutrophil elastase compared with sc
neutrophil elastase (Table 2).
Pathogenicity of the tc-form of mouse neutrophil elastase. The
basic experiment leading to the protease–antiprotease concept
was the intratracheal instillation or aerosol inhalation of purified
proteases in animal models including papain, porcine pancreatic
elastase, human PR3 or human neutrophil elastase1,2. All these
proteases, however, have different cleavage specificities and
affinities for endogenous mouse inhibitors21–24. To overcome
these experimental limitations, we applied and evaluated for the
first time mouse neutrophil elastase as an experimental inducer of
lung emphysema and also considered the tc-form of neutrophil
elastase as a potential pathogenic trigger in vivo. Our in vivo
experiments with quantitative assessment of airspace enlargement
ascertained the pathogenic role of the endogenous murine
homologue and, moreover, revealed that the autoprocessed
form of mouse neutrophil elastase induced similar emphysema-
like changes in mouse lung tissues as the sc-form after 2 months
(Fig. 5). Both forms, sc and tc neutrophil elastase, induced an
inflammatory infiltrate of cells within 24 h, in particular, of
macrophages and of neutrophils, but not of lymphocytes, which
was verified by lung tissue staining and analysis of
bronchoalveolar lavage (BAL) fluids (Fig. 6a,b). Compared with
buffer controls, these cellular findings are paralleled by an



















Figure 2 | Double internal cleavages appear to inactivate neutrophil
elastase. Neutrophil elastase was incubated with biotinylated AAPV-
chloromethylketone (neutrophil elastase inhibitor) at 37 C for 30 min.
(a) Eight mg of wild-type or mutated mouse neutrophil elastase (wt mNE or
mut mNE) was separated by SDS–PAGE and stained with Coomassie blue.
There were equal amounts of band 3 and 4. (b) One mg of each mouse
neutrophil elastase form was separated by SDS–PAGE and analysed by
western blotting using avidin-HRP. The signal for band 3 was much stronger
compared with band 4. (c) Scheme showing the molecular structure of the
three neutrophil elastase bands. The lowest band (4) contains single-nicked
mouse neutrophil elastase as well as double-nicked mouse neutrophil
elastase. The double-nicked mouse neutrophil elastase does not appear to
react with the chloromethylketone as judged from the reduced western blot
signal (b) in comparison with the total amount of the tc neutrophil elastase































Figure 3 | The tc- and sc-form of neutrophil elastase in human and
murine neutrophils. (a) Mouse neutrophils were purified from bone
marrow cells. Total cell lysates were analysed by SDS–PAGE and western
blotting using an anti-neutrophil elastase polyclonal antibody. To
demonstrate the specificity of the antibody for neutrophil elastase, lysates
from PR3/NE double-knockout mice were processed in the same way and
absence of similar immunoreactive fragments was verified (left lane).
(b) Human PMNs were isolated from peripheral blood leukocytes and
incubated with a biotinylated tetrapeptide (AAPV) chloromethyl ketone
inhibitor during lysis. After immunoprecipitation with an anti-human
neutrophil elastase monoclonal antibody and SDS–PAGE followed by
western blotting, active site-labelled human neutrophil elastase was
visualized using horseradish peroxidase-conjugated streptavidin. Two bands
co-migrating with the respective bands of a human neutrophil elastase
preparation from sputum were active site labelled by the chloromethyl
ketone indicating the occurrence of an active tc neutrophil elastase (tc-NE)
in biological samples. Both experiments were repeated thrice.
Table 1 | Autocleavage of mouse neutrophil elastase
changed substrate specificity.
Km [lM] kcat [s 1] kcat/Km [M 1 s 1]
AAT: Mca-GEAIPMSIPPEVK(Dnp)-rr
sc-mNE 26.6 (±7.3) 4.51 (±0.01) 16.9 (±4.6) 105
tc-mNE 28.9 (±6.5) 0.360 (±0.008) 1.24 (±.03) 105
MNEI: Mca-GIATFCMLMPEQ-(Dnp)-rr
sc-mNE 11.4 (±3.6) 0.660 (±0.002) 5.77 (±1.8) 105
tc-mNE 2.1 (±0.8) 0.023 (±0.001) 1.10 (±0.5) 105
AAT, alpha-1-antitrypsin; Sc-mNE, single-chain mouse neutrophil elastase; tc-mNE, two-chain
mouse neutrophil elastase.
The two substrates are derived from the reactive center loop of AAT and MNEI, respectively, and
are cleaved after the underlined residue. For the AAT-derived substrate, the Km values for the sc
and tc neutrophil elastase (sc-mNE and tc-mNE) differed only minimally, but kcat of the sc
neutrophil elastase was 12.5-fold higher than that of the tc neutrophil elastase. The difference in
kcat values for the MNEI-substrate was even higher (29-fold) for the sc and tc neutrophil
elastase, but in contrast to the AAT-substrate, the Km for tc neutrophil elastase was fivefold
lower.
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the RNA (data not shown) and protein level (Fig. 6c) attracting
monocytes and neutrophils, respectively.
Discussion
In this study, a self-cleavage site at Ala188/Gly189 was
identified in both recombinant as well as in native neutrophil
elastase from PMNs. We studied autoprocessing of neutro-
phil elastase only in two mammalian species human neutrophil
elastase and mouse neutrophil elastase, but as this combination of
Ala–Gly at position 188 and 189 occurs in many mammalian
species, autoprocessing of neutrophil elastase appears to be a
general mechanism to regulate neutrophil elastase activity and
specificity.
Self-cleavage after residue Ala188 in neutrophil elastase occurs
within a flexible loop of the activation domain of which Val190
and Phe192 affect the S1 subsite in neutrophil elastase25 and
influence interactions with substrates. As there was a 10-times
decline in the association rate constant of neutrophil elastase with
AAT after self-cleavage, we proved that cleavage of this loop
affected the interaction of peptides with the substrate-binding
region of neutrophil elastase and the association rate of AAT with
the tc neutrophil elastase. A more direct indication for our
suggestion that the S1 pocket was affected by autoprocessing is
the 14-fold increase in the dissociation constant of a small-
molecule inhibitor kindly provided by AstraZeneca. The key
interaction of this non-covalently bound chemical (compound
10)26 involves the deep insertion of the N-aryl group into the S1-
binding pocket and additional hydrogen bonds between the
pyridone and benzylamide moieties and neutrophil elastase (Peter
Sjö, personal communication). These structural determinants of
inhibitor binding are consistent with our observations of its
reduced inhibitory activity on the tc-form of neutrophil elastase.
Elevated local flexibility of the S1-binding groove evidently
impairs the drug-target interplay and local dynamics of inhibitor
recognition.
Oropharyngeal application of sc and tc neutrophil elastase to
mice showed that the pathogenic potential of NE was not lost
after autoprocessing, and tc neutrophil elastase was still able to
induce emphysema-like changes in mice. Direct comparisons of
the effects of the sc-mutant and the tc-form for wild-type mouse
neutrophil elastase, however, should be made with caution
because of the lower stability of the tc-form during in vitro
production and processing, The lower number of infiltrating cells
and neutrophils (Fig. 5b) could be interpreted as a trend towards
a slightly reduced pathogenicity of the tc-form, but the variability
of the effects observed with it were relatively large compared with
those of the sc-mutant. By contrast, macrophage levels in the BAL
fluids did not differ between the sc- and the tc-elastase groups
despite lower monocyte-recruiting CCL2 levels (Fig. 5c). Other
monocyte-recruiting factors, for example, fragments of elastin27
and of other matrix components, directly produced by the
instilled elastase preparations, may be more relevant for tc
neutrophil elastase-induced monocyte recruitment than CCL2
induction in this experimental model.
As neutrophils are recruited at high densities to sites of
invading bacteria or external noxious agents like cigarette smoke
and nanoparticles, release of the proteolytically modified elastase
from activated neutrophils, dying neutrophils and neutrophils
engaged in frustrated phagocytosis should primarily contribute to
the damage of lung tissues that are particularly exposed to
environmental triggers, as seen in patients with AAT deficiencies.
Up to now, small-molecule inhibitors were developed and
optimized to target the sc-from of neutrophil elastase, as the
existence of a post-translationally modified neutrophil elastase
escaped attention or was simply ignored. Recognition of the tc
neutrophil elastase as an additional pathogenic factor in
neutrophil-mediated tissue damage necessitates the design of
Table 2 | Impaired inhibition of tc-NE.
Inhibitor Inhibition type sc-mNE tc-mNE
AAT Irreversible Kass [M
 1 s 1] 33.5 (±28.2) 105 3.4 (±2.2) 105
AZ11117736 Competitive Kd [mM] 3.3 (±0.9) 10 7 46.8 (±12) 10 7
Sc-mNE, single-chain mouse neutrophil elastase; tc-mNE, two-chain mouse neutrophil elastase.
The association rate constant Kass for the inhibition of the tc-NE by the irreversible inhibitor AAT was almost 10-fold lower than that for the sc-NE, which indicates a slower inhibition of tc-NE by AAT. The
small-molecule inhibitor, kindly provided to us from AstraZeneca, is a non-covalently bound compound. The dissociation constant Kd of tc-NE and this chemical is 14-fold higher than that of sc-NE. In
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Figure 4 | Impaired inhibition of tc mouse neutrophil elastase by AAT.
Wild-type or mutated mouse neutrophil elastase (wt mNE or mut mNE)
was mixed with AAT at a ratio of 2:3 and incubated at 37 C. A covalent
bond is formed between the Ser195 of neutrophil elastase and the Met358
of AAT. To study the complex formation over time, aliquots were withdrawn
at the indicated time points and analysed by SDS–PAGE and Coomassie
staining. (a) The tc neutrophil elastase–AAT complex (tc-AAT) is smaller
than the sc neutrophil elastase–AAT complex (sc-AAT) as only the small 7-
kDa carboxyl-terminal fragment of tc mouse neutrophil elastase remains
covalently bound to AAT in reducing conditions. While sc neutrophil
elastase–AAT complexes form within seconds, tc neutrophil elastase–AAT
complex formation takes several minutes. (b) Mutated mouse neutrophil
elastase consists of almost exclusively sc neutrophil elastase. The reaction
with AAT is finished after ten seconds. Both experiments were repeated
thrice.
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new inhibitors to target both NE forms with equal efficacy in
the future.
Methods
Expression and purification of proteins. Mouse neutrophil elastase was amplified
by the PCR from a complementary DNA clone. An artificial propeptide termi-
nating in the sequence DDDK, an enterokinase cleavage site (DDDK), was fused to
the N terminus of the mature elastase reading frame using the following oligo-
duplex DJ3385 50Pho-CAG GTT CCA CTG GTA GCC GCA TGC ACC GCA
ACG GCA GCC AC-30 and DJ3386 50-Pho-GTG GCT GCC GTT GCG GTG CAT
GCG GCT ACC AGT GGA ACC TGG TAC-30 . To enable secretion, the Igk-chain
secretion signal was added with an oligoduplex, DJ2972 50-Pho-CTA GCC ACC
ATG GAG ACA GAC ACA CTC CTG CTA TGG GTA CTG CTG CTC TGG
GTAC CAG GTT CCA C-30 and DJ2973 50-Pho-GT GGA ACC TGG TAC CCA
GAG CAG CAG TAC CCA TAG CAG GAG TGT GTC TGT CTC CAT GGT
GG-30 (Metabion, Martinsried, Germany) and cloned into the pcDNA5/FRT vector
(Thermo Fisher Scientific Inc., Waltham, MA, USA) in frame with the codons for 6
histidine residues (6His-tag) at the 30-end to facilitate purification of the
recombinant protein. Finally, this construct was inserted into the NheI and NaeI
site of the expression vector pTT5 (National Research Council of Canada, Quebec,
Canada).
A self-cleavage-resistant form of mouse neutrophil elastase was made with the
help of the oligoduplex DJ3395 50-Pho-GTG AAC GTA TGC ACT CTG GTG
CCA CGT CGA AAG GGT GGC ATC TGC TTC GGG GAC TCT-30 and DJ3396




















































































































Figure 6 | Sc and tc mouse neutrophil elastase induce inflammation in lung. Mice were analysed 24 h after a single oropharyngeal application of sc
neutrophil elastase (sc-NE), tc neutrophil elastase (tc-NE) or buffer (300 mM NaCl, 20 mM Na2HPO4 pH7.4). (a) Representative micrographs of lung
tissue were stained with haematoxylin and eosin (scale bars, 100mm). The severity of inflammation was calculated using a five-point lung inflammation
scoring system (0, no inflammation and 5, 430 inflammatory cells per field). Inflammation was more severe in mice treated with sc- or tc-mNE than buffer
alone. (b) The amount of inflammatory cells in BAL was significantly increased in the BAL of sc- and tc-mNE-treated mice. Analysing May–Grünwald–
Giemsa-stained cytospin slides revealed neutrophils as the main population followed by macrophages. (c) The protein level of two important chemokines
MCP1/CCL2 and KC/CXCL1 were determined using ELISA. The sc- and tc-mNE-treated mice showed a significantly higher level of MCP1/CCL2 and KC/
CXCL1 compared with buffer-treated mice. Data (mean±s.e.m.) are representative of two independent experiments with total n¼ 7 (sc-NE) and n¼8













Figure 5 | Pathogenicity of the tc-form of mouse neutrophil elastase. (a) Representative micrographs of haematoxylin and eosin-stained lung tissue 2
months after a single oropharyngeal application of sc neutrophil elastase (sc-NE), tc neutrophil elastase (tc-NE) or buffer (300 mM NaCl, 20 mM Na2HPO4
pH7.4; scale bars, 100mm). (b) Unlike buffer-exposed mice, tc-NE and sc-NE treatment generated a marked airspace enlargement, confirmed by mean
chord length (MCL) determination of buffer, sc-NE and tc-NE exposed mouse lungs. Data (mean±s.e.m.) are representative of two independent
experiments with n¼ 3 (buffer) and n¼4 (sc- or tc-NE). One-way analysis of variance Bonferroni test was applied (**Po0.01, ***Po0.001).
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AGT GCA TAC GTT CAC AC-30, changing the residues Gln187–Ala188 of mouse
neutrophil elastase to Lys187–Gly188.
All proteins were expressed in HEK293 EBNA cells (Yves Durocher, National
Research Council Canada, Montreal, Canada) that were grown as suspension
culture in FreeStyleTM 293 expression medium (Thermo Fisher Scientific Inc.), 1%
Pluronic and G418 (25 mg ml 1) at 37 C and 8% CO2. Cells were transfected using
polyethylenimine–DNA complexes. Elastase variants were purified using PrepEase
Histidine-tagged Protein Purification Midi Kit—High Specificity (Affymetrix, Santa
Clara, USA) according to the manufacturer’s instructions.
Determination of active mouse neutrophil elastase. Trypsin was burst titrated
in veronal buffer with 4-nitrophenyl 4-guanidinobenzoate (Sigma-Aldrich, St
Louis, USA)28 and then used for the titration of AAT. Different concentrations of
standardized AAT (Athens Research & Technology, Athens, GA, USA) were
incubated with a constant volume of mouse neutrophil elastase at 37 C for 1 h.
Thereafter, the residual activity was measured. The tc mouse neutrophil elastase
was titrated using 1 mM Boc-Ala-Pro-Nva-4-chloro-SBzl (Bachem, Bubendorf,
Switzerland) together with 0.5 mM 50,50-dithio-bis(2-nitrobenzoic acid), while
0.5 mM MeOSuc-AAPV-pNA substrate was used for the measurement of sc mouse
neutrophil elastase activities. All reactions were performed in 150 mM NaCl,
50 mM Tris, 0.01% Triton-X-100, pH7.4. The absorbance was monitored at a
wavelength of 405 nm and 22 C.
Km and catalytic rate constant kcat. Active mouse neutrophil elastase con-
centrations for the determination of the Michaelis–Menten constant (Km) were
either 23 nM sc mouse neutrophil elastase or 231 nM tc mouse neutrophil elastase.
Concentrations of the substrates ([S]) MCA-GEAIPMSIPPEVK(Dnp)-rr (EMC
microcollections, Tübingen, Germany) were varied between 1 and 80 mM and
plotted against reaction rate. Data were fitted to the Michaelis–Menten equation
using GraphPad Prism (GraphPad Software Inc., La Jolla, USA). In case all
enzymes bind substrates, the catalytic rate constant (kcat) is obtained with equa-
tion (1). [E] is the total enzyme concentration. The fluorescence was measured at
405 nm after excitation at 320 nm.
kcat ¼ vmax/½E ð1Þ
Inhibitor constants. In the presence of a competitive inhibitor (I), the Michaelis–
Menten kinetics are given by equation (2). Initial enzyme reaction rates (v0) were
determined as a function of the substrate concentration in the absence and pre-
sence of five different inhibitor concentrations ([I]). The inhibition constant Ki was







For irreversible inhibition, inhibitor constants were obtained using the conditions
described by Duranton and Bieth29. To avoid substrate depletion, [S] was five times
higher than Km. To keep [I] constant, [I] was at least five times higher than the
enzyme concentration. mNE (10 nM) was added to a mix of 60–700 nM of
inhibitor and 152 mM substrate MCA-GEAIPTSIPPEVK(Dnp)-rr (EMC
microcollections GmbH, Tübingen, Germany). The fluorescence progression curve
was recorded immediately (excitation 320 nm, emission 405 nm) thereafter. Using
GraphPad Prism, the progression curves were fitted to equation (3) and the
observed Michaelis–Menten constant (kobs) was obtained.
P½  ¼ v0
kobs
 
1 e kobs t
 
ð3Þ
Plotting kobs against the inhibitor concentration and fitting it to equation (4)
(GraphPad Prism), the apparent inhibitor constant (Ki(app)) was determined. The










Identification of neutrophil elastase in biological samples. Isolated PMNs from
the peripheral blood were lysed in RIPA-buffer (30 mM Tris-HCl pH8, 150 mM
NaCl, 0.5% deoxycholate, 0.1% SDS, 1% IGEPAL CA-630, 1 mM EDTA) in the
presence of 20 nM biotinylated AAPV-chloromethyl ketone inhibitor. Inhibited
human neutrophil elastase was captured with 8 mg anti-human neutrophil elastase
antibodies (QED Biosciences Inc., San Diego, USA, Cat. No.12303) at 4 C after
overnight incubation. Protein G dynabeads (Life technologies, Invitrogen) were
used according to the manufacturer’s instructions to isolate the antibody–antigen
complexes. Making use of the biotinylated AAPV-chloromethyl ketone, active
human neutrophil elastase was detected with streptavidin-HRP after the precipitate
was separated by SDS–PAGE and blotted. Sputum derived human neutrophil
elastase (Elastin Products Company, Owensville, MO, USA) was used as a control.
Murine PMNs were isolated from the bone marrow of female 129S6/SvEv mice
(wild type and PR3/NE-deficient) aged 8–10 weeks and directly boiled in Laemmli
sample buffer at 95 C under reducing conditions. Western blotting after SDS–
PAGE was performed with anti-NE antibodies (Abcam; Cambridge, UK, ab68672,
dilution 1:1,000) and secondary peroxidase-conjugated anti-rabbit antibodies
(Jackson Immunoresearch Laboratories, USA; cat. No. 111-035-006, dilution
1:5,000).
Animal experiments. Female C57BL/6 mice, 8–10 weeks old, were treated with sc
neutrophil elastase or tc neutrophil elastase in 80 ml volume per mouse (4 mg
protease per kg body weight) by an oropharyngeal mode. Control mice (n¼ 3)
received 80ml sterile buffer (300 mM NaCl, 20 mM Na2HPO4 pH7.4). Mice were
killed after 2 months for the long-term experiments. The animal study was repe-
ated twice with four mice in each mouse neutrophil elastase group. For the analysis
of cell influx and chemokine levels, the mice were killed after 24 h. The animal
study was performed twice with four mice in both tc neutrophil elastase and buffer
control groups and three and four mice in the sc neutrophil elastase groups. All
experiments were conducted under strict governmental and international guide-
lines and were approved by the local government for the administrative region of
Upper Bavaria.
Embedding and staining. Left lungs were inflated with 6% paraformaldehyde in
PBS at 20 cm H2O pressure. To obtain systematic uniform random sampling, the
lung block embedded in agar, was cut into 2 mm thick slices using a tissue matrix.
Afterwards the lung slices were embedded in paraffin and stained with haema-
toxylin and eosin.
Morphometry. An Olympus BX51 light microscope equipped with a computer-
assisted stereological toolbox (NewCAST of Visiopharm, Hoersholm Denmark)
was used to analyse the lung sections. A line grid was superimposed on images of
lung section at  20 objective. Intercepts of lines with alveolar septa and points







Pair¼ sum points of the
grid hitting air spaces, L(p)¼ line length per point,
P
Isepta¼ sum of intercepts of
alveolar septa with grid lines.
Histological scoring. The severity of lung inflammation was scored by examining
haematoxylin and eosin-stained lung sections using a five-point lung inflammation
scoring system. Each lung was scored on each slide at a magnification of 20-fold.
Within each field, inflammatory cells were assigned according to predominated
criteria—0, no inflammation; 1, o5 inflammatory cells per field; 2, 6–10 inflam-
matory cells per field; 3, 10–20 inflammatory cells per field; 4, 20–30 inflammatory
cells per field; 5, 430 inflammatory cells per field.
Preparation of BAL. BAL was obtained to analyse the total and differential cell
counts for inflammatory cell recruitment of neutrophils and macrophages. The
lungs were lavaged by instilling the lungs with 2 0.5 ml aliquots of sterile PBS
(Gibco, Life Technologies, Darmstadt, Germany). For cytospins, cells were spun
down at 400g for 20 min and resuspended in RPMI-1640 medium containing 10%
fetal calf serum (both from Gibco). Total cell counts were determined in a hae-
mocytometer. Differential cell counts were performed using morphological criteria
on May–Grünwald–Giemsa-stained cytospin slides (200 cells per sample). BAL
fluid was used to evaluate cytokine secretion.
Measurement of cytokines and chemokines. Monocyte chemotactic protein 1
(MCP1/CCL2) and keratinocyte chemoattractant (KC/CXCL1) levels were deter-
mined in BAL fluid using commercially available ELISA kits (R&D Systems Eur-
ope, Abingdon, UK) according to the manufacturer’s instructions. In brief, a 96-
well microplate was coated with diluted capture antibody (100 ml per well) and
incubated overnight at room temperature (RT). Followed by blocking with reagent
diluent (1% bovine serum albumin in PBS, pH 7.2–7.4) at RT for 1 h, the sample or
standard was added to each well and incubated at RT for 2 h. Next, the plate was
incubated with detection antibody diluted in reagent diluent at RT for 2 h. Sub-
sequently, a working dilution of Streptavidin-HRP was added to each well and
incubated for 20 min at RT in the dark. Next, the plate was incubated with sub-
strate solution at 1:1 ratio of colour reagent A H2O2 and colour reagent B (tetra-
methylbenzidine) also for 20 min at RT in the dark. Finally, 50 ml of stop solution
(2 N H2SO4) was added. The plate was gently tapped to ensure thorough mixing.
Optical density was determined immediately, using a microplate reader set to
450 nm. Of note, each incubation step is followed by washing three times with wash
buffer (0.05% Tween 20 in PBS, pH 7.2–7.4).
Statistics. Results are given as mean values±s.e.m. The one-way analysis of
variance Bonferroni test was applied in all studies (*Po0.05, **Po0.01,
***Po0.001). Analyses were conducted by use of GraphPad Prism 6 software
(GraphPad Software).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7722 ARTICLE
NATURE COMMUNICATIONS | 6:6722 | DOI: 10.1038/ncomms7722 | www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
References
1. Wright, J. L., Cosio, M. & Churg, A. Animal models of chronic obstructive
pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L1–15 (2008).
2. Korkmaz, B., Horwitz, M. S., Jenne, D. E. & Gauthier, F. Neutrophil elastase,
proteinase 3, and cathepsin G as therapeutic targets in human diseases.
Pharmacol. Rev. 62, 726–759 (2010).
3. Brebner, J. A. & Stockley, R. A. Recent advances in a-1-antitrypsin deficiency-
related lung disease. Expert. Rev. Respir. Med. 7, 213–229 (2013).
4. Gooptu, B. & Lomas, D. A. Conformational pathology of the serpins: themes,
variations, and therapeutic strategies. Annu. Rev. Biochem. 78, 147–176 (2009).
5. Cavarra, E. et al. Effects of cigarette smoke in mice with different levels of
alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am. J. Respir. Crit.
Care Med. 164, 886–890 (2001).
6. Scott, A., Weldon, S. & Taggart, C. C. SLPI and elafin: multifunctional
antiproteases of the WFDC family. Biochem. Soc. Trans. 39, 1437–1440 (2011).
7. Zani, M.-L. et al. SLPI and trappin-2 as therapeutic agents to target airway
serine proteases in inflammatory lung diseases: current and future directions.
Biochem. Soc. Trans. 39, 1441–1446 (2011).
8. Garver, R. I. et al. Alpha 1-antitrypsin deficiency and emphysema caused by
homozygous inheritance of non-expressing alpha 1-antitrypsin genes. N. Engl.
J. Med. 314, 762–766 (1986).
9. Campbell, E. J., Campbell, M. A., Boukedes, S. S. & Owen, C. A. Quantum
proteolysis by neutrophils: implications for pulmonary emphysema in
a1-antitrypsin deficiency. J. Clin. Invest. 104, 337–344 (1999).
10. Bode, W. et al. X-ray crystal structure of the complex of human leukocyte
elastase (PMN elastase) and the third domain of the turkey ovomucoid
inhibitor. EMBO J. 5, 2453–2458 (1986).
11. Witt, H. et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant
protects against chronic pancreatitis. Nat. Genet. 38, 668–673 (2006).
12. Schoellmann, G. & Shaw, E. Direct evidence for the presence of histidine in the
active center of chymotrypsin. Biochemistry 2, 252–255 (1963).
13. Smith, R. L. & Shaw, E. Pseudotrypsin. A modified bovine trypsin produced by
limited autodigestion. J. Biol. Chem. 244, 4704–4712 (1969).
14. Hedstrom, L., Szilagyi, L. & Rutter, W. J. Converting trypsin to chymotrypsin:
the role of surface loops. Science 255, 1249–1253 (1992).
15. Iversen, L. F. et al. Structure of HBP, a multifunctional protein with a serine
proteinase fold. Nat. Struct. Biol. 4, 265–268 (1997).
16. Pfister, H. et al. Antineutrophil cytoplasmic autoantibodies against the murine
homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood
104, 1411–1418 (2004).
17. Perera, N. C. et al. NSP4 is stored in azurophil granules and released by
activated neutrophils as active endoprotease with restricted specificity.
J. Immunol. 191, 2700–2707 (2013).
18. Travis, J. & Salvesen, G. S. Human plasma proteinase inhibitors. Annu. Rev.
Biochem. 52, 655–709 (1983).
19. Huntington, J. A. Shape-shifting serpins–advantages of a mobile mechanism.
Trends Biochem. Sci. 31, 427–435 (2006).
20. Cooley, J., Takayama, T. K., Shapiro, S. D., Schechter, N. M. & Remold-
O’Donnell, E. The serpin MNEI inhibits elastase-like and chymotrypsin-like
serine proteases through efficient reactions at two active sites. Biochemistry 40,
15762–15770 (2001).
21. Hill, R. E. & Hastie, N. D. Accelerated evolution in the reactive centre regions of
serine protease inhibitors. Nature 326, 96–99 (1987).
22. Clauss, A., Lilja, H. & Lundwall, A. The evolution of a genetic locus encoding
small serine proteinase inhibitors. Biochem. Biophys. Res. Commun. 333,
383–389 (2005).
23. Barbour, K. W. et al. Functional diversification during evolution of the murine
a1-proteinase inhibitor family: role of the hypervariable reactive center loop.
Mol. Biol. Evol. 19, 718–727 (2002).
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